Chip stocks fall with Nvidia after data center rev disappointment
LONDON - CVS Group plc (LSE:CVS), a UK-listed veterinary services provider, has awarded options over 276,364 ordinary shares to executives and employees under its Long Term Incentive Plan 2025, according to a press release issued Friday.
The company granted 79,550 options to Chief Executive Officer Richard Fairman, 54,495 to Chief Financial Officer Robin Alfonso, and 46,774 to Chief Veterinary Officer Paul Higgs. The remaining options were distributed to other employees.
The stock options have an exercise price of 0.2 pence per share and will vest in three years, subject to performance criteria. Vesting depends on the company’s earnings per share growth and total shareholder return over the three-year period from July 1, 2025, to June 30, 2028.
The transactions were executed on July 31, 2025, and were reported in accordance with UK Market Abuse Regulation requirements.
CVS Group operates as a provider of veterinary services in the United Kingdom (TADAWUL:4280). The company’s shares trade on the London Stock Exchange (LON:LSEG) under the ticker symbol CVS.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.